Senseonics, Roche expand distribution deal for Eversense glucose monitor

Senseonics (NYSE:SENS) said today that it expanded its exclusive distribution agreement with Roche (PINK:RHHBY) for its implantable continuous glucose monitoring system for people with diabetes. The new agreement includes all of Europe, the Middle East and Africa, excluding Scandinavia, Finland and Israel.

According to the agreement, Germantown, Maryland-based Senseonics has given Roche exclusive rights to promote, market and sell the Eversense system in specified territories. Senseonics will still be responsible for product development, regulatory approval, quality management and manufacturing, while Roche will take over commercializing the system.

Get the full story at our sister site, Drug Delivery Business News.

 

The post Senseonics, Roche expand distribution deal for Eversense glucose monitor appeared first on MassDevice.

from MassDevice http://ift.tt/2fPKO9q